BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4308712)

  • 1. [A study of the soluble antigens of strains of Cl. perfringens isolated from the feces of healthy persons].
    Goeva OE; Borovik EB; Sidorenko GI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):43-6. PubMed ID: 4308712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and function of Cl. perfringens toxin].
    Ispolatovskaia MV
    Vestn Akad Med Nauk SSSR; 1973; 28(11):83-9. PubMed ID: 4132138
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens.
    Möllby R; Nord CE; Wadström T
    Toxicon; 1973 Feb; 11(2):139-47. PubMed ID: 4351816
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.
    Smyth CJ; Arbuthnott JP
    J Med Microbiol; 1974 Feb; 7(1):41-66. PubMed ID: 4369079
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of Cl. perfringens lecithinase in the effect of the toxin on tissue cultures].
    Shamraeva SA; Shemanova GF; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):20-4. PubMed ID: 4305232
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on intra- and interspecies relationships of bacterial hemolysins. 1. Identification of marked and masking toxin relationships of Cl. perfringens. Efficiency of the serum-unmasking test for the diagnosis of the classical C-subtype].
    Marica D; Klemm W; Vasiu C
    Zentralbl Veterinarmed B; 1975 Apr; 22(3):196-204. PubMed ID: 178124
    [No Abstract]   [Full Text] [Related]  

  • 7. [The differentiation of clostridia. 6. Differentiation of Cl. septicum and Cl. chauvoei].
    al-Khatib G
    Arch Exp Veterinarmed; 1969 Nov; 23(5):963-70. PubMed ID: 4919644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some data in favor of the enzymatic nature of Cl. perfringens and oedematiens toxins].
    Zhak SP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):65-9. PubMed ID: 4290470
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study of the enzymes of the toxic Cl. perfringens complex, their formation and interaction].
    Ispolatovskaia MV; Mikhaĭlovskaia LIa; Klimacheva LV; Blagoveshchenskiĭ VA; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):61-5. PubMed ID: 4290256
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunochemical study of the enzymes of a toxic complex of Cl. perfringens].
    Ispolatovskaia MV; Klimacheva LV; Tokinova TN; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):89-93. PubMed ID: 4327165
    [No Abstract]   [Full Text] [Related]  

  • 11. [The diffusion factor of C1. perfringens types A, B, C, D, E and F].
    Marasonova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Mar; 46(3):131-4. PubMed ID: 4306555
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cultural properties of C1. perfringens resistant and sensitive to morphocycline].
    Miasnikova IG; Bel'kevich EA
    Antibiotiki; 1977 Nov; 22(11):1008-11. PubMed ID: 202190
    [No Abstract]   [Full Text] [Related]  

  • 13. The lecithinase (alpha toxin) activity of strains of Clostridium perfringens.
    Nakamura M; Cross WR
    Proc Soc Exp Biol Med; 1968 Mar; 127(3):719-22. PubMed ID: 4297194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the in vitro cytotoxic activity, lecithinase activity and lethality in mice of Clostridium welchii alpha-toxin].
    Collotti C; Piccoli F; Vella L; Zampieri A
    Ann Ist Super Sanita; 1968; 4(5):633-40. PubMed ID: 4308896
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological properties of Cl. perfringens type A, isolated from human subjects inhabiting a hermetic chamber].
    Shilov VM; Zemlianitskaia EP; Borisova OK
    Kosm Biol Aviakosm Med; 1976; 10(3):71-5. PubMed ID: 9533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of toxic enzymes of Clostridium perfringens BP6K on technologically important media including a medium with Tween 80.
    Lettl A
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(2):243-8. PubMed ID: 217931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences between the biochemical structure of the bacterium W. perifringens A and its toxin].
    Katitch RV; Gadjansky G; Dimitrievitch M; Voukitchevitch Z; Militch D
    Rev Immunol Ther Antimicrob; 1967; 31(4):355-60. PubMed ID: 4294159
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of the reciprocal relationship of the exoantigens of Clostridium perfringens type A in the culture medium and the bacterial cells during cultivation.
    Shemanova GF; Gorshkova VI; Borisova OK; Shakhanina KL
    Folia Microbiol (Praha); 1970; 15(1):23-33. PubMed ID: 4312434
    [No Abstract]   [Full Text] [Related]  

  • 19. [The variability of individual properties of subcultures of Cl. perfringens type A grown from separate colonies of strain BP6K (28)].
    Shemanova GF; Petrov RV; Borisova OK
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):85-9. PubMed ID: 4308062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the antigenic structure of anatoxins of Clostridium perfringens, Cl. oedematiens, Cl. septicum and Cl. tetani by determining their fixation properties].
    Kalinichenko NF
    Mikrobiol Zh; 1966; 28(4):75-7. PubMed ID: 4297189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.